Phase 3 randomized study of Daratumumab plus lenalidomide and Dexamethasone (D-Rd) versus lenalidomide and Dexamethasone (Rd) in patients with newly diagnosed multiple myeloma (NDMM) ineligible for transplant (MAIA)

被引：0

作者：

Weisel, K. ^{[1
,2
]}

Facon, T. ^{[3
]}

Kumar, S. ^{[4
]}

Plesner, T. ^{[5
,6
]}

Orlowski, R. Z. ^{[7
]}

Moreau, P. ^{[8
]}

Bahlis, N. ^{[9
]}

Basu, S. ^{[10
]}

Nahi, H. ^{[11
]}

Hulin, C. ^{[12
]}

Quach, H. ^{[13
]}

Goldschmidt, H. ^{[14
,15
]}

O'Dwyer, M. ^{[16
]}

Perrot, A. ^{[17
]}

Venner, C. P. ^{[18
]}

Mace, J. R. ^{[19
]}

Ahmadi, T. ^{[20
]}

Chiu, C. ^{[21
]}

Wang, J. ^{[22
]}

van Rampelbergh, R. ^{[23
]}

Uhlar, C. M. ^{[21
]}

Kobos, R. ^{[21
]}

Qi, M. ^{[21
]}

Usmani, S. Z. ^{[24
]}

机构：

[1] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany

[2] Eberhard Karls Univ Tubingen, Univ Klinikum Tubingen, Tubingen, Germany

[3] Hop Claude Huriez, Serv Malad Sang, Lille, France

[4] Mayo Clin Rochester, Dept Hematol, Rochester, MN USA

[5] Vejle Hosp, Vejle, Denmark

[6] Univ Southern Denmark, Vejle, Denmark

[7] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA

[8] Univ Hosp Hotel Dieu, Hematol, Nantes, France

[9] Univ Calgary, Arnie Charbonneau Canc Inst, Calgary, AB, Canada

[10] Royal Wolverhampton Hosp NHS Trust, Wolverhampton, W Midlands, England

[11] Karolinska Inst, Karolinska Univ Hosp Huddinge, Div Hematol, Dept Med, Stockholm, Sweden

[12] Univ Hosp, Hosp Haut Leveque, Dept Hematol, Pessac, France

[13] Univ Melbourne, St Vincents Hosp, Melbourne, Vic, Australia

[14] Univ Hosp Heidelberg, Heidelberg, Germany

[15] Natl Ctr Tumor Dis NCT, Heidelberg, Germany

[16] NUI, Dept Med, Haematol, Galway, Ireland

[17] Univ Hosp, Dept Hematol, Vandoeuvre Les Nancy, France

[18] Univ Alberta, Div Med Oncol, Edmonton, AB, Canada

[19] Florida Canc Specialists & Res Inst, St Petersburg, Russia

[20] Genmab US Inc, Princeton, NJ USA

[21] Janssen Res & Dev, Spring House, PA USA

[22] Janssen Res & Dev, Raritan, NJ USA

[23] Janssen Res & Dev, Beerse, Belgium

[24] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P715

引用

页码：194 / 194

页数：1